Proteome Sciences plc
PRM.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | £9 | £10 | £11 | £13 |
| - Cash | £0 | £1 | £1 | £2 |
| + Debt | £15 | £15 | £14 | £13 |
| Enterprise Value | £24 | £24 | £23 | £25 |
| Revenue | £2 | £3 | £2 | £2 |
| % Growth | -30.4% | 20.4% | 21.9% | – |
| Gross Profit | -£0 | £0 | £1 | -£12,623 |
| % Margin | -4.8% | 2.2% | 27.6% | -694,329.5% |
| EBITDA | -£1 | -£0 | -£1 | -£1 |
| % Margin | -65.1% | -9% | -57.6% | -69.4% |
| Net Income | -£2 | -£1 | -£2 | -£2 |
| % Margin | -115.2% | -44.7% | -99.8% | -102.6% |
| EPS Diluted | -0.007 | -0.004 | -0.008 | -0.006 |
| % Growth | -80% | 46.7% | -19% | – |
| Operating Cash Flow | -£1 | -£0 | -£1 | -£8,961 |
| Capital Expenditures | -£0 | -£0 | -£0 | -£1,718 |
| Free Cash Flow | -£1 | -£1 | -£1 | -£10,679 |